» Articles » PMID: 19553685

Inactivation of Mammalian Target of Rapamycin Increases STAT1 Nuclear Content and Transcriptional Activity in Alpha4- and Protein Phosphatase 2A-dependent Fashion

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Jun 26
PMID 19553685
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Target of rapamycin (TOR) is a highly conserved serine/threonine kinase that controls cell growth, primarily via regulation of protein synthesis. In Saccharomyces cerevisiae, TOR can also suppress the transcription of stress response genes by a mechanism involving Tap42, a serine/threonine phosphatase subunit, and the transcription factor Msn2. A physical association between mammalian TOR (mTOR) and the transcription factor signal transducer and activator of transcription-1 (STAT1) was recently identified in human cells, suggesting a similar role for mTOR in the transcription of interferon-gamma-stimulated genes. In the current study, we identified a macromolecular protein complex composed of mTOR, STAT1, the Tap42 homologue alpha4, and the protein phosphatase 2A catalytic subunit (PP2Ac). Inactivation of mTOR enhanced its association with STAT1 and increased STAT1 nuclear content in PP2Ac-dependent fashion. Depletion of alpha4, PP2A, or mTOR enhanced the induction of early (i.e. IRF-1) and late (i.e. caspase-1, hiNOS, and Fas) STAT1-dependent genes. The regulation of IRF-1 or caspase-1 by mTOR was independent of other known mTOR effectors p70 S6 kinase and Akt. These results describe a new role for mTOR and alpha4/PP2A in the control of STAT1 nuclear content, and the expression of interferon-gamma-sensitive genes involved in immunity and apoptosis.

Citing Articles

Inhibition of autophagosome-lysosome fusion contributes to TDCIPP-induced Aβ1-42 production in N2a-APPswe cells.

Zou C, Yang T, Huang X, Ren X, Yang C, Xu B Heliyon. 2024; 10(8):e26832.

PMID: 38628727 PMC: 11019100. DOI: 10.1016/j.heliyon.2024.e26832.


Cyclin G2 in macrophages triggers CTL-mediated antitumor immunity and antiangiogenesis via interferon-gamma.

Liu L, Gao J, Xing X, Jiang M, Liu Q, Wang S J Exp Clin Cancer Res. 2022; 41(1):358.

PMID: 36566226 PMC: 9789679. DOI: 10.1186/s13046-022-02564-2.


Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow.

Xiong F, Wang Q, Wu G, Liu W, Wang B, Chen Y Biomark Res. 2022; 10(1):69.

PMID: 36104718 PMC: 9472737. DOI: 10.1186/s40364-022-00415-y.


Alpha4 contributes to the dysfunction of the pancreatic beta cell under metabolic stress.

Hali M, Wadzinski B, Kowluru A Mol Cell Endocrinol. 2022; 557:111754.

PMID: 35987388 PMC: 9620510. DOI: 10.1016/j.mce.2022.111754.


L-Leucine Promotes STAT1 and ISGs Expression in TGEV-Infected IPEC-J2 Cells mTOR Activation.

Du J, Chen D, Yu B, He J, Yu J, Mao X Front Immunol. 2021; 12:656573.

PMID: 34367129 PMC: 8339710. DOI: 10.3389/fimmu.2021.656573.


References
1.
NANAHOSHI M, Nishiuma T, Tsujishita Y, Hara K, Inui S, Sakaguchi N . Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42. Biochem Biophys Res Commun. 1998; 251(2):520-6. DOI: 10.1006/bbrc.1998.9493. View

2.
Kristof A, Marks-Konczalik J, Billings E, Moss J . Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin. J Biol Chem. 2003; 278(36):33637-44. DOI: 10.1074/jbc.M301053200. View

3.
Kong M, Fox C, Mu J, Solt L, Xu A, Cinalli R . The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis. Science. 2004; 306(5696):695-8. DOI: 10.1126/science.1100537. View

4.
Murata K, Wu J, Brautigan D . B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc Natl Acad Sci U S A. 1997; 94(20):10624-9. PMC: 23426. DOI: 10.1073/pnas.94.20.10624. View

5.
Shuai K, Liu B . Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol. 2005; 5(8):593-605. DOI: 10.1038/nri1667. View